Cowen Inc’s Ocular Therapeutix OCUL Stock Holding History

Cowen Inc’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-49,200	Closed	-$456K	–	281
2017 Q2	$456K	Buy	+49,200	New	+$476K	0.02%	225
2017 Q1	–	Sell	-71,375	Closed	-$597K	–	289
2016 Q4	$597K	Buy	71,375 +2,975	+4%	+$23.1K	0.02%	177
2016 Q3	$470K	Sell	68,400 -58,504	-46%	-$357K	0.03%	189
2016 Q2	$628K	Sell	126,904 -18,796	-13%	-$186K	0.04%	148
2016 Q1	$1.41M	Buy	145,700 +130,700	+871%	+$990K	0.05%	127
2015 Q4	$141K	Buy	+15,000	New	+$162K	0.01%	272

Other funds holding OCUL

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cowen Inc's OCUL Position: Q3 2017 in Review

Cowen Inc sold out of Ocular Therapeutix (OCUL) in Q3 2017, closing a stake of 49,200 shares — an estimated $456K sold.

Cowen Inc first reported a position in OCUL in Q4 2015 and held it in 6 quarters. The position peaked at $1.41M in Q1 2016. 73 funds tracked by Wall St. Rank hold OCUL as of Q3 2017.

Cowen Inc reported no remaining Ocular Therapeutix position as of Q3 2017 after selling out during the quarter.
Cowen Inc sold 49,200 Ocular Therapeutix shares in Q3 2017, an estimated $456K.
Cowen Inc first reported a position in Ocular Therapeutix in Q4 2015 and held it in 6 quarters.
Cowen Inc's Ocular Therapeutix position peaked at $1.41M in Q1 2016.
73 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2017.

Based on Cowen Inc's 13F filing for Q3 2017, filed 14 Nov 2017.